The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4
Open accessAbstract
Metastasis of cancer cells is a complex process involving multiple steps including invasion, angiogenesis, and trafficking of cancer cells through blood vessels, extravasations, organ-specific homing, and growth. While matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines play a major role in invasion and angiogenesis, chemokines such as stromal derived factor-1alpha (SDF-1alpha) and their receptors such as CXCR4 are thought to play a critical role in motility, homing, and proliferation of cancer cells at specific metastatic sites. We and others have previously reported that the extracellular signal-activated transcription factor NF-kappaB up-regulates the expression of matrix metalloproteinases, urokinase-type plasminogen activator, and cytokines in highly metastatic breast cancer cell lines. In this report, we demonstrate that NF-kappaB regulates the motility of breast cancer cells by directly up-regulating the expression of CXCR4. Overexpression of the inhibitor of kappaB (IkappaB) in breast cancer cells with constitutive NF-kappaB activity resulted in reduced expression of CXCR4 and a corresponding loss of SDF-1alpha-mediated migration in vitro. Introduction of CXCR4 cDNA into IkappaB-expressing cells restored SDF-1alpha-mediated migration. Electrophoretic mobility shift assays and transient transfection assays revealed that the NF-kappaB subunits p65 and p50 bind directly to sequences within the -66 to +7 region of the CXCR4 promoter and activate transcription. We also show that the cell surface expression of CXCR4 and the SDF-1alpha-mediated migration are enhanced in breast cancer cells isolated from mammary fat pad xenografts compared with parental cells grown in culture. A further increase in CXCR4 cell surface expression and SDF-1alpha-mediated migration was observed with cancer cells that metastasized to the lungs. Taken together, these results implicate NF-kappaB in the migration and the organ-specific homing of metastatic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMD231 cells were obtained from Dr. Harikrishna Nakshatri in 2009 and are a derivative of the MDA-MB-231 cell line (19).”
From Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model (2015) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,582
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat‐Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 818
Self-citationBargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 757
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Sato, H., & Seiki, M. (1993) · PubMed · Cited by 695
Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W., & Groopman, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23169 · Cited by 614
Flagged first, then by citations
Research works printed but not linked: 8
- Sato, 1993, Oncogene, 8, 395
- Andela, 2000, Cancer Res., 60, 6557
- Dong, 1999, Cancer Res., 59, 3495
- Shattuck-Brandt, 1997, Cancer Res., 57, 3032
- Bachelder, 2002, Cancer Res., 62, 7203
- Koshiba, 2000, Clin. Cancer Res., 6, 3530
- Murakami, 2002, Cancer Res., 62, 7328
- Scotton, 2002, Cancer Res., 62, 5930
Cited by
Sorted by citations
Items 301–400 of 640
Ansah, C., & Mensah, K. B. (2013) · PubMed Central · Cited by 42
Andrographolide inhibits melanoma tumor growth by inactivating the TLR4/NF-κB signaling pathway
Zhang, Q.-Q., Zhou, D., Ding, Y., Liu, H., Lei, Y., Fang, H., Gu, Q., He, X., Qi, C., Yang, Y., et al. (2014) · Melanoma Research · doi:10.1097/cmr.0000000000000117 · Cited by 40
Baek, S. H., Kim, S., Nam, D., Lee, J., Ahn, K. S., Choi, S., Kim, S., Shim, B. S., Chang, I., & Ahn, K. S. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.664151 · Cited by 40
CXCR4 overexpression is correlated with poor prognosis in colorectal cancer
Xu, C., Zheng, L., Li, D., Chen, G., Gu, J., Chen, J., & Yao, Q. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.050 · Cited by 40
Yenmiş, G., Saraç, E. Y., Beşli, N., Soydaş, T., Taştan, C., Kançağı, D. D., Yılancı, M., Şenol, K., Karagülle, O. O., Ekmekçi, C. G., et al. (2021) · Acta Histochemica · doi:10.1016/j.acthis.2021.151709 · Cited by 40
Wang, Y., Chen, Y.-K., Lo, S. J., Chi, T., Chen, Y., Hu, S. C., Chen, Y., Jiang, S. S., Tsai, F., Liu, W., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01698-5 · Cited by 42
Wu, T., Kooi, C. W. V., Shah, P., Charnigo, R. J., Huang, C., Smyth, S. S., & Morris, A. J. (2013) · The FASEB Journal · doi:10.1096/fj.13-232868 · Cited by 40
Greco, S. J., Patel, S. A., Bryan, M., Pliner, L. F., Banerjee, D., & Rameshwar, P. (2011) · Europe PMC (PubMed Central) · Cited by 39
Wehler, T. C., Graf, C., Biesterfeld, S., Brenner, W., Schadt, J., Gockel, I., Berger, M. R., Thüroff, J. W., Galle, P. R., Moehler, M. H., et al. (2008) · Journal of Oncology · doi:10.1155/2008/626340 · Cited by 40
SDF-1α Promotes Invasion of Head and Neck Squamous Cell Carcinoma by Activating NF-κB
Rehman, A. O., & Wang, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710432200 · Cited by 39
Thalidomide treatment down-regulates SDF-1α and CXCR4 expression in multiple myeloma patients
Oliveira, A. M., Maria, D. A., Metzger, M., Linardi, C. C. G., Giorgi, R. R., Moura, F., Martınez, G., Bydlowski, S. P., & Novak, E. M. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.018 · Cited by 39
Lam, T., Kulp, D., Wang, R., Lou, Z., Taylor, J. R., Rivera, C. E., Yan, H. M., Zhang, Q., Wang, Z., Zan, H., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601427 · Cited by 37
Kim, N. Y., Jung, Y. Y., Yang, M. H., Um, J., Sethi, G., & Ahn, K. S. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110433 · Cited by 40
Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration
Shao, H., Xu, Q., Wu, Q., Ma, Q., Salgueiro, L., Wang, J., Eton, D., Webster, K. A., & Yu, H. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01231.x · Cited by 40
The Nuclear Factor-Kappa B Pathway and Response to Treatment in Breast Cancer
Park, Y. H. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0044 · Cited by 38
Stoll, G., Pol, J. G., Soumelis, V., Zitvogel, L., & Kroemer, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1484980 · Cited by 38
Luo, C., Pan, H., Mines, M. A., Watson, K., Zhang, J., & Fan, G.-H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605837200 · Cited by 38
The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers
Midavaine, É., Côté, J., & Sarret, P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09974-2 · Cited by 39
Cohen, J., Chen, Z., Lu, S., Yang, X. P., Arun, P., Ehsanian, R., Brown, M. S., Lü, H., Yan, B., Diallo, O. T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3704 · Cited by 37
Goldberg-Bittman, L., Sagi‐Assif, O., Meshel, T., Nevo, I., Levy‐Nissenbaum, O., Yron, I., Witz, I. P., & Ben‐Baruch, A. (2004) · Cytokine · doi:10.1016/j.cyto.2004.10.003 · Cited by 37
Massa, A., Casagrande, S., Bajetto, A., Porcile, C., Barbieri, F., Thellung, S., ARENA, S., Pattarozzi, A., Gatti, M., Corsaro, A., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.042 · Cited by 37
Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion
Miyanishi, N., Suzuki, Y., Simizu, S., Kuwabara, Y., Banno, K., & Umezawa, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.007 · Cited by 36
Khan, P., Manna, A., Saha, S., Mohanty, S., Mukherjee, S., Mazumdar, M., Guha, D., & Das, T. (2016) · BMC Cancer · doi:10.1186/s12885-016-2078-7 · Cited by 35
Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm
Nengroo, M. A., Khan, M. A., Verma, A., & Datta, D. B. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188790 · Cited by 37
Gupta, N., Mohan, C. D., Shanmugam, M. K., Jung, Y. Y., Chinnathambi, A., Alharbi, S. A., Ashrafizadeh, M., Mahale, M., Bender, A., Kumar, A. P., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116335 · Cited by 36
Annexin-A1 controls an ERK-RhoA–NFκB activation loop in breast cancer cells
Bist, P., Phua, Q., Shu, S., Yuan, Y., Anbalagan, D., Lee, L. H., Sethi, G., Low, B. C., & Lim, L. H. K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.166 · Cited by 35
SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines
Pan, F., Ma, S., Cao, W.-K., Liu, H., Chen, F., Chen, X., & Shi, R. (2013) · Molecular Biology Reports · doi:10.1007/s11033-012-2225-4 · Cited by 35
Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma
Singh, A., Srivastava, N., Yadav, A., & Ateeq, B. (2020) · Neoplasia · doi:10.1016/j.neo.2020.08.002 · Cited by 35
de Jong, E., Winkel, P., Poelstra, K., & Prakash, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025192 · Cited by 35
Sandhu, C., Hewel, J. A., Badis, G., Talukder, S., Liu, J., Hughes, T. R., & Emili, A. (2008) · Journal of Proteome Research · doi:10.1021/pr700836q · Cited by 35
Weitzenfeld, P., Kossover, O., Körner, C., Meshel, T., Wiemann, S., Seliktar, D., Legler, D. F., & Ben‐Baruch, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ma0815-373r · Cited by 34
Liu, P., He, K., Song, H., Ma, Z., Yin, W.-H., & Xu, L. X. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.014 · Cited by 35
Deregulated transcription factors and poor clinical outcomes in cancer patients
Li, Y., Azmi, A. S., & Mohammad, R. M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.001 · Cited by 33
Xia, J., Wang, F., Wang, L., & Fan, Q. (2012) · Tumor Biology · doi:10.1007/s13277-012-0553-6 · Cited by 34
Es-Haghi, M., Soltanian, S., & Dehghani, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-4690-6 · Cited by 34
Kasagi, Y., Harada, Y., Morodomi, Y., Iwai, T., Saito, S., Yoshida, K., Oki, E., Saeki, H., Ohgaki, K., Sugiyama, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1563 · Cited by 34
Al‐Awadhi, F. H., Paul, V. J., & Luesch, H. (2018) · ChemBioChem · doi:10.1002/cbic.201700627 · Cited by 34
Kunigal, S., Lakka, S. S., Joseph, P. A., Estes, N. C., & Rao, J. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2060 · Cited by 34
Averett, C., Bhardwaj, A., Arora, S., Srivastava, S. K., Khan, M. A., Ahmad, A., Singh, S., Carter, J. E., Khushman, M. M., & Singh, A. P. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw096 · Cited by 34
Perumal, E., Mercy, A. B., Arunkamar, R., Sharmila, G., Bhat, F. A., Balakrishnan, S., Singh, P., & Arunakaran, J. (2014) · Cell Proliferation · doi:10.1111/cpr.12148 · Cited by 33
Wang, J., Cai, J., Han, F., Yang, C., Tong, Q., Cao, T., Wu, L., & Wang, Z. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31821d2543 · Cited by 32
Yang, K. (2014) · Medical Science Monitor · doi:10.12659/msm.892597 · Cited by 32
Akt plays an important role in breast cancer cell chemotaxis to CXCL12
Zhao, M., Mueller, B. M., DiScipio, R. G., & Schraufstätter, I. U. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9712-7 · Cited by 34
Elshafae, S. M., Kohart, N. A., Altstadt, L. A., Dirksen, W. P., & Rosol, T. J. (2017) · The Prostate · doi:10.1002/pros.23318 · Cited by 31
Biswas, S., Chowdhury, S. R., Mandal, G., Purohit, S., Gupta, A., & Bhattacharyya, A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.002 · Cited by 31
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Zhang, Y., Zhou, F., Guan, J., Zhou, L., & Chen, B. (2023) · Biomolecules · doi:10.3390/biom13020250 · Cited by 38
Markers in normal and cancer stem cells
Natarajan, T. G., & Fitzgerald, K. T. (2007) · Cancer Biomarkers · doi:10.3233/cbm-2007-34-506 · Cited by 30
Effect of Goji (Lycium barbarum) on Expression of Genes Related to Cell Survival
Lin, N.-C., Lin, J.-C., Chen, S.-H., Ho, C., & Yeh, A. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2021754 · Cited by 31
Inhibition of the NF-κB Signaling Pathway by a Novel Heterocyclic Curcumin Analogue
Katsori, A., Palagani, A., Bougarne, N., Hadjipavlou‐Litina, D., Haegeman, G., & Berghe, W. V. (2015) · Molecules · doi:10.3390/molecules20010863 · Cited by 31
Chemokine–Chemokine Receptors in Cancer Immunotherapy
Stewart, T. J., & Smyth, M. J. (2008) · Immunotherapy · doi:10.2217/1750743x.1.1.109 · Cited by 31
Guenzle, J., Wolf, L. J., Garrelfs, N. W. C., Goeldner, J. M., Osterberg, N., Schindler, C. R., Saavedra, J. E., & Weyerbrock, A. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.6 · Cited by 31
Ruan, J., Liao, Y., Lua, I., Li, M.-H., Hsu, C.-Y., & Chen, J. H. (2012) · Breast Cancer Research · doi:10.1186/bcr3226 · Cited by 30
Salata, G. C., Malagó, I. D., Dartora, V. F. C., Pessoa, A. F. M., Fantini, M. C. D. A., Costa, S. K. P., Machado‐Neto, J. A., & Lopes, L. B. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00319 · Cited by 30
Park, B.-H., Kook, S., Lee, S., Jeong, J., Brufsky, A., & Lee, B.-C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.509505 · Cited by 30
Weng, J., Tsai, C.-H., Omar, H. A., Sargeant, A. M., Wang, D.-S., Kulp, S. K., Shapiro, C. L., & Chen, C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp202 · Cited by 30
Matteucci, E., Ridolfi, E., Maroni, P., Bendinelli, P., & Desiderio, M. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0054 · Cited by 32
Targeting Inflammatory Mediators: An Anticancer Mechanism of Thymoquinone Action
Akter, Z., Ahmed, F. H., Tania, M., & Khan, M. A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191011143642 · Cited by 33
Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis
Hattinger, E., Zwicker, S., Ruzicka, T., Yuspa, S. H., & Wolf, R. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.04.007 · Cited by 31
Mmu-miR-1894-3p Inhibits Cell Proliferation and Migration of Breast Cancer Cells by Targeting Trim46
Zhang, L., Li, X., Dong, W., Sun, C., Guo, D., & Zhang, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040609 · Cited by 29
Vykhovanets, E. V., Shukla, S., MacLennan, G. T., Vykhovanets, O. V., Bodner, D. R., & Gupta, S. (2009) · The Prostate · doi:10.1002/pros.20916 · Cited by 29
Villablanca, E. J., Zhou, D., Valentinis, B., Negro, A., Raccosta, L., Mauri, L., Prinetti, A., Sonnino, S., Bordignon, C., Traversari, C., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108047 · Cited by 27
Ramadoss, S., Li, J., Ding, X., Hezaimi, K. A., & Wang, C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00576-10 · Cited by 28
Lee, K. W., Lim, S., & Kim, K. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169365 · Cited by 30
Chang, Y.-W., Chen, M.-W., Chiu, C., Hong, C., Cheng, C.-C., Hsiao, M., Chen, C., Wei, L., & Su, J.-L. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3812-5 · Cited by 28
Pan, C., Chen, C.-W., Sheu, M., & Wu, C. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.11.008 · Cited by 28
Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network
Bahrami, T., & Mehdipour, P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9023-z · Cited by 28
Infection and Inflammation: Impacts on Oncogenesis
Dittmar, T., Zaenker, K. S., & Schmidt, A. (2006) · Contributions to microbiology · doi:10.1159/isbn.978-3-318-01310-8 · Cited by 28
Han, N., Li, X., Wang, Y., Wang, L. Q., Zhang, C., Zhang, Z., Ruan, M., & Zhang, C. (2021) · Journal of Cancer · doi:10.7150/jca.55580 · Cited by 27
Altenburg, J. D., Harvey, K. A., McCray, S., Xu, Z., & Siddiqui, R. A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.172 · Cited by 27
Murphy, T., Hori, S., Sewell, J., & Gnanapragasam, V. J. (2010) · International Journal of Cancer · doi:10.1002/ijc.25542 · Cited by 27
The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes
Rascle, A., Neumann, T., Raschta, A., Neumann, A., Heining, E., Kastner, J., & Witzgall, R. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.012 · Cited by 26
Alipanah, H., Bigdeli, M. R., & Esmaeili, M. A. (2018) · Europe PMC (PubMed Central) · Cited by 27
Combined Prognostic Value of Both RelA and IκB-α Expression in Human Non–Small Cell Lung Cancer
Zhang, D., Jin, X., Wang, F., Wang, S., Deng, C., Gao, Z., & Guo, C. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9560-z · Cited by 27
Comparison of 18F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression
Zhang, X., Sun, Z., Guo, J., Wang, Z., Wu, C., Niu, G., Ma, Y., Kiesewetter, D. O., & Chen, X. S. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0640-0 · Cited by 28
Role of Berberine on molecular markers involved in migration of esophageal cancer cells.
Mishan, M. A., Ahmadiankia, N., Matin, M. M., Heirani‐Tabasi, A., Shahriyari, M., Bidkhori, H. R., Naderi‐Meshkin, H., & Bahrami, A. R. (2015) · PubMed · Cited by 26
Cell-Free Biological Approach for Corneal Stromal Wound Healing
Jhanji, V., Billig, I., & Yam, G. H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671405 · Cited by 27
Relationship Between Vascular Endothelial Growth Factor and Nuclear Factor-κB in Renal Cell Tumors
Đorđević, G., Matušan‐Ilijaš, K., Sinožić, E., Damante, G., Fabbro, D., Grahovac, B., Lučin, K., & Jonjić, N. (2008) · Croatian Medical Journal · doi:10.3325/cmj.2008.5.608 · Cited by 26
Young, B., Purcell, C., Kuang, Y., Charette, N., & Dupré, D. J. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438566 · Cited by 26
Sun, J., Nemoto, E., Hong, G., & Sasaki, K. (2016) · BMC Oral Health · doi:10.1186/s12903-016-0250-8 · Cited by 26
Thomas, N. P., Wu, W. J., Fleming, B. C., Wei, F., Chen, Q., & Lei, W. (2017) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-017-1913-6 · Cited by 26
Jang, S., Kim, Y. S., Kim, Y. R., Sung, H. J., & Ko, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607962200 · Cited by 26
Evaluation of tissue‐specific promoters in carcinomas of the cervix uteri
Rein, D., Breidenbach, M., Nettelbeck, D. M., Kawakami, Y., Siegal, G. P., Huh, W. K., Wang, M., Hemminki, A., Bauerschmitz, G. J., Yamamoto, M., et al. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.606 · Cited by 26
Serum chemokine network correlates with chemotherapy in non-small cell lung cancer
Yang, D., Zhou, J., Zeng, T., Yang, Z., Wang, X., Hu, J., Song, Y., Chen, L., Peer, D., Wang, X., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.001 · Cited by 25
Li, S., Fan, T., Liu, H., Chen, J., Qin, C., & Ren, X. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2675-3 · Cited by 25
Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling
Penzo, M., Habiel, D. M., Ramadass, M., Kew, R. R., & Marcu, K. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.04.011 · Cited by 24
Lee, H., Ko, J., Baek, S. H., Nam, D., Lee, S., Lee, J., Yang, W. M., Um, J., Kim, S., Shim, B. S., et al. (2016) · Phytotherapy Research · doi:10.1002/ptr.5612 · Cited by 25
Ding, Y., Zhang, L., Goodwin, J. S., Wang, Z., Liu, B., Zhang, J., & Fan, G.-H. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.10.032 · Cited by 25
Wang, L., Kuang, L., Hitron, J. A., Son, Y., Wang, X., Budhraja, A., Lee, J., Pratheeshkumar, P., Chen, G., Zhang, Z., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.028 · Cited by 23
Gao, M., Yeh, P.-Y., Lu, Y., Chang, W. C., Kuo, M., & Cheng, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.144 · Cited by 24
Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues
Kochan, D. Z., Ilnytskyy, Y., Golubov, A., Deibel, S. H., McDonald, R. J., & Kovalchuk, O. (2015) · Oncoscience · doi:10.18632/oncoscience.157 · Cited by 23
Xiaoxia, X., Sun, J., Dongbin, X., Tian, Y., Jingke, Z., Zhang, Y., & Hulai, W. (2020) · Current Drug Delivery · doi:10.2174/1567201817666200115105633 · Cited by 23
Xu, X., Xia, Y., Ma, J., Li, W., Niu, N., Li, X., Tao, H., Xu, J., & He, X. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5072 · Cited by 23
Richard, C. L., Lowthers, E. L., & Blay, J. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.06.027 · Cited by 23
Fibroblasts Promote Proliferation and Matrix Invasion of Breast Cancer Cells in Co‐Culture Models
Plaster, M., Singh, S. K., & Tavana, H. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900121 · Cited by 27
Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer
Tsoli, E., Tsantoulis, P. K., Papalambros, A., Perunović, B., England, D., Rawlands, D. A., Reynolds, G. M., Vlachodimitropoulos, D. G., Morgan, S. L., Spiliopoulou, C., et al. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.037887 · Cited by 23
Aronica, S. M., Fanti, P., Kaminskaya, K., Gibbs, K., Raiber, L., Nazareth, M. R., Bucelli, R. C., Mineo, M., Grzybek, K., Kumin, M., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000019961.59306.f6 · Cited by 23
Biomaterials to suppress cancer stem cells and disrupt their tumoral niche.
Garcia-Mazas, C., Csaba, N., & Garcia-Fuentes, M. (2017) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2016.12.013 · Cited by 19
Dwyer, A., Kerkvliet, C. P., Krutilina, R., Playa, H. C., Parke, D., Thomas, W., Smeester, B., Moriarity, B., Seagroves, T., & Lange, C. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0295 · Cited by 19
Sugamata, N., Okuyama, T., Takeshita, E., Oi, H., Hakozaki, Y., Miyazaki, S., Takada, M., Mitsui, T., Noro, T., Yoshitomi, H., et al. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02578-2 · Cited by 22
Sun, Y., Zhao, Z., & Zhu, H. (2015) · Oncology Letters · doi:10.3892/ol.2015.3220 · Cited by 22
Metadata
- Authors
- Helbig, G., Christopherson, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., & Nakshatri, H.
- Affiliations
- Indiana University Indianapolis (US)
- Walther Cancer Foundation (US)
- Corresponding author
- Nakshatri, Harikrishna
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 24
- Pages
- 21631-21638
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1980790180
- Cited by
- 639
- References
- 42
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 12 · 2022: 19 · 2021: 14 · 2020: 23 · 2019: 18 · 2018: 33 · 2017: 28 · 2016: 34 · 2015: 30 · 2014: 35 · 2013: 42 · 2012: 18
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health (5r21ca082208-02)
- National Heart, Lung, and Blood Institute (HL67384, R01HL067384)
- National Cancer Institute (CA82208)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK053674, DK53674, T32DK007519)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- NF-κB, breast cancer, metastasis, cell migration, CXCR4, chemokine receptors, SDF-1α, chemokine signaling, IκB, transcriptional regulation, lung metastasis
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Chemotaxis, Flow Cytometry, Genetic Vectors, Humans, Neoplasm Metastasis, Neoplasm Transplantation, Plasmids, Promoter Regions, Genetic, Ribonucleases, RNA, Messenger, Transcription, Genetic, Transfection, Tumor Cells, Cultured, Up-Regulation, Gene Expression Regulation, Neoplastic, NF-kappa B, DNA, Complementary, COS Cells, Receptors, CXCR4, Matrix Metalloproteinases, Mitogen-Activated Protein Kinases, Transcription Factor RelA, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review